Drug Type Live biotherapeutic products |
Synonyms EDP 1066, EDP1066 |
Target- |
Action modulators |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Mild Atopic Dermatitis | Phase 1 | United Kingdom | 24 Apr 2019 | |
| Moderate Atopic Dermatitis | Phase 1 | United Kingdom | 24 Apr 2019 | |
| Plaque psoriasis | Phase 1 | United Kingdom | 24 Apr 2019 | |
| Colitis, Ulcerative | Preclinical | United States | - | |
| Crohn Disease | Preclinical | United States | - |





